Home | Articles
Published on:March 2020
Indian Journal of Pharmaceutical Education and Research, 2020; 54(2):349-356
Original Article | doi:10.5530/ijper.54.2.40

Cytotoxicity and Pharmacokinetic Studies of PLGA Based Capecitabine Loaded Nanoparticles

Authors and affiliation (s):

Goutam Kumar Jena1,*, Chinam Niranjan Patra1, Prasanna Kumar Dixit2

1Department of Pharmaceutics, Roland Institute of Pharmaceutical Sciences, Berhampur, BPUT, Rourkela, Odisha, INDIA.

2Department of Zoology, Berhampur University, Berhampur, Ganjam, Odisha, INDIA.


Background: Colorectal cancer ranked fourth as devastating cancer globally based on statistical death analysis. The major challenge for treating colorectal cancer is to target the drug to the specific site of the colon. Purpose: The main objective of the present research was to develop PLGA based nanoparticles to target and sustain the drug release at the colon for effective treatment of colorectal cancer. The significance of using Eudragit S100 was to prevent drug release in the stomach and small intestine whereas the significance of PLGA is to sustain drug release by its mucoadhesion property. Methods: Nanoparticles were prepared by modified nanoprecipitation method and the cytotoxicity study was performed by MTT assay. Results: From the cytotoxicity study it was found that Capecitabine loaded PLGA based nanoparticles had more capacity to inhibit HT 29 cell lines than that of the pure drug for all concentrations (10 to 0.0001). Pharmacokinetic (PK) study for the aqueous suspension of Capecitabine and optimized formulation ratified the results of in vitro study. The Area under the curve (AUC) for nanoparticles formulation was found to be twice more than the pure drug indicating better bioavailability. Conclusion: The PLGA based nanoparticles can be better targeted to colon for effective treatment of colorectal cancer.

Key words: Capecitabine, Colorectal, Cancer, Cytotoxicity, MTT, PLGA.



Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).


Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

User login

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.


IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs